|Last Price$68.44||Day Change (%)1.23%|
|Open Price$67.80||Day Change ($)0.83|
|Day Range67.61–68.58||52-Week Range53.08–70.66|
As of Thu 04/17/2014 04:14 PM EST | USD
The Deal Announces Candidates For Seventh Annual Most Admired Corporate Dealmakers Awards
Slowly and steadily, industrial demand is continuing unabated, both in the U.S. and, surprisingly, in Europe.
The newly public AbbVie's dividend will be too concentrated to a single drug, while the payout from the remaining Abbott entity won't be as generous as in years past, according to Morningstar's Josh Peters.
Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may ...
The current industrial slowdown could persist for several additional quarters, but we think pockets of value exist.
Which stocks have performed best, and what can investors expect going forward?
Cost-conscious investors can use ETFs to implement themes similar to those of smart, well-respected active mutual fund managers.